<DOC>
	<DOCNO>NCT01477138</DOCNO>
	<brief_summary>Background : - Potential negative effect pace RV-apex well document - However , study result compare septal / RVOT-pacing versus RV-apical pacing controversial . - The optimal pacing mode SSS ( DDDR versus AAIR ) unclear , DDD ( R ) mode AV delay ≤ 220 m prefer pace mode , accord DANPACE trial [ DANPACE , ESC 2010 , Stockholm ] . Aim : - evaluate chronic effect proven right ventricular septal compare minimize right ventricular septal pacing patient SSS Inclusion criterion : -Pacemaker indication accord current guideline : sick sinus syndrome ( SSS ) Exclusion criterion : - Life expectancy &lt; 2 year - Age &lt; 18 year - Noncompliance regard participation study - Pregnancy - AV block ° 2 high - Permanent atrial fibrillation - Heart failure NYHA III IV , reduce LV-EF &lt; 40 % - ICD indication - Acute coronary syndrome . PCI CABG &lt; 3 month - Heart transplant - Placement septal RV electrode possible Study design : - Prospective , monocentric , randomize , double-blinded - Run-in phase : week AAI [ R ] -DDD [ R ] - Randomization : two group A ) septal right ventricular chamber pacing : mode DDD [ R ] versus B ) Reduction unnecessary ventricular pacing : AAI [ R ] -DDD [ R ] . - FU : 6 12-months Primary endpoint : -LV ejection fraction end-systolic LV volume 12 month . Secondary endpoint : -LV end-diastolic volume , TAPSE , parameter dyssynchrony ( SPWMD , LV-PEP , IVMD ) , AF-burden , % ventricular pacing , CPX : peak oxygen consumption ( peak VO2 ) , VO2 AT , VO2/HR , VE/VCO2 slope ; QoL score ( SF-36 ) 12 month . Statistics/sample size estimation : In order detect difference LVEF 5 % LV-ESV 5 mL 2 group 12 month : - 90 % power/alpha 5 % : 84 patient per group - 80 % power/alpha 5 % : 63 patient per group - 10 % compensation drop-outs / patient lose follow-up . Two-sided 5 % type 1 error Analysis intention-to-treat base finally program pacing mode . Material - PG : market release dual chamber pacemaker ability pace AAI ( R ) -DDD ( R ) - pace lead : market-released standard active electrode - RV electrode : septal verify multi-level screening ( RAO/LAO ) ECG ( LBBB narrow &lt; 150 m / inferior axis )</brief_summary>
	<brief_title>RV Septal Versus Minimized RV Pacing Sick Sinus Syndrome</brief_title>
	<detailed_description>Background : - Potential negative effect pace RV-apex well document - Asynchronous ventricular activation - reduction systolic diastolic LV function - Experimental data : histological change - Asymmetric LV hypertrophy thin - However , study result compare septal / RVOT-pacing versus RV-apical pace controversial : - Acute versus chronic - Small number case , uncontrolled , unblinded , - Brief period observation cross-over design ( 3 month ) - `` RVOT '' often summarize different stimulation site : high RVOT , lateral , septal . Actually limited data proven septal stimulation - No objective performance assessment ( CPX ) - Assessment alternative stimulation site previously RVOT versus RV-apex , - ventricular pacing compare ventricular pacing , test potential harm another - The question optimal pacing mode patient SSS ( DDDR versus AAIR ) appear open . While Germany , two-chamber system AAI [ R ] mode ventricular back-up use , DDD ( R ) mode AV delay ≤ 220 m prefer pace mode , accord result DANPACE trial patient SSS [ DANPACE , ESC 2010 , Stockholm ] . Aim : - evaluate chronic effect proven right ventricular septal compare minimize right ventricular septal pacing patient SSS Inclusion criterion : -Pacemaker indication accord current guideline : sick sinus syndrome ( SSS ) Exclusion criterion : - Life expectancy &lt; 2 year - Age &lt; 18 year - Noncompliance regard participation study - Pregnancy - AV block ° 2 high - Permanent atrial fibrillation - Heart failure NYHA III IV , reduce LV-EF &lt; 40 % - ICD indication - Acute coronary syndrome . PCI CABG &lt; 3 month - Heart transplant - Placement septal RV electrode possible Study design : - Prospective , monocentric , randomize , double-blinded - Run-in phase : 4 week AAI [ R ] -DDD [ R ] - ECG , PM-interrogation , echocardiography , performance diagnostics , CPX , QoL questionnaire - Randomization : two group 4 week ( 3 6 week ) implant A ) septal right ventricular chamber pacing : mode DDD [ R ] versus B ) Reduction unnecessary ventricular pacing : AAI [ R ] -DDD [ R ] . - FU : 6 12-months - ECG , Holter-ECG , PM-interrogation , echocardiography , performance diagnostics , CPX , QoL questionnaire - Extension follow-up possible Primary endpoint : -LV ejection fraction end-systolic LV volume 12 month . Secondary endpoint : -LV end-diastolic volume , TAPSE , parameter dyssynchrony ( SPWMD , LV-PEP , IVMD ) , AF-burden , % ventricular pacing , CPX : peak oxygen consumption ( peak VO2 ) , VO2 AT , VO2/HR , VE/VCO2 slope ; QoL score ( SF-36 ) 12 month . Blinding : - Patient compare pace mode - Physician : offline analysis echo CPX blind pace mode Statistics/sample size estimation : In order detect difference LVEF 5 % LV-ESV 5 mL 2 group 12 month : - 90 % power/alpha 5 % : 84 patient per group - 80 % power/alpha 5 % : 63 patient per group - 10 % compensation drop-outs / patient lose follow-up . Two-sided 5 % type 1 error Analysis intention-to-treat base finally program pacing mode . Material - PG : market release dual chamber pacemaker ability pace AAI ( R ) -DDD ( R ) - pace lead : market-released standard active electrode ( eg . BSCI FineLine 4470 4471 ) Implantation - Transvenously - RA-electrode : possible , short atrial conduction time - RV electrode : septal verify multi-level screening ( RAO/LAO ) ECG ( LBBB narrow &lt; 150 m / inferior axis )</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Pacemaker indication accord current guideline : sick sinus syndrome ( SSS ) Life expectancy &lt; 2 year Age &lt; 18 year Noncompliance regard participation study Pregnancy AV block ° 2 high Permanent atrial fibrillation Heart failure NYHA III IV , reduce LVEF &lt; 40 % ICD indication Acute coronary syndrome . PCI CABG &lt; 3 month Heart transplant Placement septal RV electrode possible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Sick Sinus Syndrome</keyword>
	<keyword>Cardiac Pacing , Artificial</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Pacemaker , Artificial</keyword>
	<keyword>SSS</keyword>
</DOC>